Alpine Global Management’s Willdan Group WLDN Stock Holding History

Alpine Global Management’s Portfolio WLDN Stock Details WLDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,443	Closed	-$860K	–	733
2021 Q4	$860K	Buy	+24,443	New	+$911K	0.13%	165

Other funds holding WLDN

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $294M AUM 19.1% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Alpine Global Management's WLDN Position: Q1 2022 in Review

Alpine Global Management sold out of Willdan Group (WLDN) in Q1 2022, closing a stake of 24,443 shares — an estimated $860K sold.

Alpine Global Management first reported a position in WLDN in Q4 2021 and held it in 1 quarter. The position peaked at $860K in Q4 2021. 99 funds tracked by Wall St. Rank hold WLDN as of Q1 2022.

Alpine Global Management reported no remaining Willdan Group position as of Q1 2022 after selling out during the quarter.
Alpine Global Management sold 24,443 Willdan Group shares in Q1 2022, an estimated $860K.
Alpine Global Management first reported a position in Willdan Group in Q4 2021 and held it in 1 quarter.
Alpine Global Management's Willdan Group position peaked at $860K in Q4 2021.
99 funds tracked by Wall St. Rank held Willdan Group as of Q1 2022.

Based on Alpine Global Management's 13F filing for Q1 2022, filed 13 May 2022.